Targeted Therapeutics Research Award
Funded equally by LUNGevity Foundation and Joan's Legacy
Carolyn Klinge, PhD
University of Louisville School of Medicine
Louisville
KY
Dr. Klinge is studying why there is a gender bias in lung adenocarcinoma that results in women being at higher risk for developing it. Her studies have revealed which proteins are expressed differently by gender in lung adenocarcinoma cells and how they could be targets of therapy in lung adenocarcinoma.